UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | SEC 1473 (7-02) | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1. Title of Derivative Security (Instr. 4) |
2. Date Exercisable and Expiration Date (Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) |
4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) |
6. Nature of Indirect Beneficial Ownership (Instr. 5) |
||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
MELLON HBV ALTERNATIVE STRATEGIES LLC 200 PARK AVE STE 3300 NEW YORK, NY 10166-3399 |
 X |  X |  | See Remarks Section |
Michael W. Hawthorne, Managing Director of Mellon HBV Alternative Strategies LLC | 10/16/2006 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | Mellon HBV (as defined below) holds through an affiliated fund 7,907,610 shares of common stock. |
(2) | Mellon HBV disclaims any pecuniary interest in the shares of common stock owned by the other Group Members (as defined below). |
 Remarks: Mellon HBV Alternative Strategies LLC ("Mellon HBV") may be deemed to be a member of a group within the meaning of Rule 13d-5  promulgated under the Securities Exchange Act of 1934, as amended, consisting of Cadence Investment Management LLC, Esopus  Creek Value LP, D. E. Shaw Laminar Portfolios, L.L.C. and the other reporting persons (collectively, the "Group Members")  identified in the Schedule 13D filed on October 10, 2006 by the Group Members.  William F. Harley III, Mellon HBV's  President and Chief Executive Officer, is now a director of the Issuer. |